Reduced serum antibody production and acute airway inflammation in interleukin 6-deficient mice challenged with ovalbumin

Allergology International

Volumn 54, Issue 2, 2005, Pages 331-338

  Kurashima, Kazuyoshi ^a,c   Tamura, Junko ^b   Fujimura, Masaki ^a   Qiu, Zhongmin ^a   Nakao, Shinji ^a   Mukaida, Naofumi ^b  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c Sailama Cardiovascular and Respiratory Center ^*  (Japan)

Author keywords

Animal; Asthma; Cytokine; Eosinophil; IL 6

Indexed keywords

CYTOKINE; CYTOKINE ANTIBODY; INTERLEUKIN 13; INTERLEUKIN 5; INTERLEUKIN 6; MESSENGER RNA; OVALBUMIN;

ACUTE DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; EOSINOPHIL; EXPOSURE; FEMALE; GENE EXPRESSION; IMMUNOGLOBULIN BLOOD LEVEL; LUNG INFILTRATE; MOUSE; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; SENSITIZATION; TH2 CELL; WILD TYPE;

EID: 21144444503     PISSN: 13238930     EISSN: None     Source Type: Journal    
DOI: 10.2332/allergolint.54.331     Document Type: Article

References (34)

1. Wills-Karp M. Immunologic basis of antigen-induced airway induced hyperresponsiveness. Ann. Rev. Immunol. 1999;17:255-281.
2. Shimura S, Ando Y, Haraguchi M, Shirato K. Continuity of airway goblet cells and intraluminal mucus in the airways of patients with bronchial asthma. Eur. Respir. J. 1996:9:1395-1401.
3. Wills-Karp M, Luyimbazi J, Xu X et al. Interleukin-13: central mediator of allergic asthma. Science 1998;282: 2258-2260.
4. Tomaki M, Zhao LL, Lundahl J et al. Eosinophilopoiesis in a murine model of allergic airway eosinophilia: involvement of bone marrow IL-5 and IL-5 receptor alpha. J. Immunol. 2000;165:4040-4050.
5. Dabbagh K, Takeyama K, Lee HM, Ueki IF, Lausier JA, Nadel JA IL-4 induces mucin gene expression and goblet cell metaplasia in vitro and in vivo. J. Immunol. 1999;162: 6233-6237.
6. Cohn L, Homer IU, Niu N, Bottomly K. T helper 1 cells and interferon γ regulate allergic airway inflammation and mucus production. J. Exp. Med. 1999;190:1309-1317.
7. Virchow JC Jr, Kroegel C, Walker C, Matthys H. Inflammatory determinants of asthma severity: mediator and cellular changes in bronchoalveolar lavage fluid of patients with severe asthma. J. Allergy Clin. Immunol. 1996; 98:527-33.
8. Konno S, Gonokami Y, Kurokawa M et al. Cytokine concentrations in the sputum of asthmatic patients. Int. Arch. Allergy Immunol. 1996;109:73-78.
9. Yokoyama A, Kohno N, Fujino S et al. Circulating interleukin-6 levels in patients with bronchial asthma. Am. J. Respir. Crit. Care Med. 1995;151:1354-1358.
10. Akira S, Taga T, Kishimoto T. Interleukin-6 in biology and medicine. Adv. Immunol. 1993;54:1-78.
11. Uyttenhove C, Coulie PG, Van Snick J. T cell growth factor and differentiation induced by interleukin-HPI/IL-6, the murine hybridoma/ plastocytoma growth factor. J. Exp. Med. 1988;167:1417-1427.
12. Rincon M, Anguita J, Nakamura T, Fikrig E, Flavell RA. Interleukin-6 directs the differentiation of IL-4-producing CD4 T cells. J. Exp. Med. 1997;185:461-470.
13. Aderka D, Le JM, Vilcek J. IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. J. Immunol. 1989;143:3517-3523.
14. Yamamoto N, Zou PJ, Li XF, Takenaka H, Fujiwara H, Hamaoka T. Regulatory mechanisms for the production of IFN-γ and TNF by antitum or T cells or macrophages in tumor-bearing state. J. Immunol. 1995;154:2281-2290.
15. Tilg H, Trehu E, Atkins MB, Dinarello CA Interleukin-6 as an antiinflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble TNF receptor p55. Blood 1994;83:113-118.
16. La Flamme AC, MacDonald AS, Pearce EJ. Role of IL-6 in directing the initial immune response to schistosome eggs. J. Immunol. 2000;164:2419-2426.
17. Baumann H, Prowse KR, Marinkovic S, Won KA, Jahreis GP. Stimulation of hepatic acute phase response by cytokines and glucocorticoids. Ann. N. Y. Acad. Sci. 1989; 557:280-295.
18. Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP. The pathophysiologic roles of interleukin-6 in human disease. Ann. Intern. Med. 1988;128:127-137.
19. Lotz M, Guerne PA. Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinases-1/erythroid potentiating activity (TIMP-1/EPA). J. Biol. Chem. 1991; 266:2017-2020.
20. Ulich TR, Yin S, Guo K, Yi ES, Remick D, del Castillo J. Intratracheal injection of endotoxin and cytokines. II. Interleukin-6 and transforming growth factor β inhibit acute inflammation. Am. J. Pathol. 1991;138:1097-1101.
21. van der Poll T, Keogh CV, Guirao X, Buurman WA, Kopf M, Lowry SF. Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia. J. Infect. Dis. 1997;176:439-444.
22. Holt PG, Macaubas PA, Stumbles PA, Sly PD. The role of allergy in the development of asthma. Nature 1999;402:B 12-17.
23. Wang J, Homer RJ, Chen Q, Elias JA. Endogenous and exogenous IL-6 inhibit aeroallergen induced Th2 inflammation. J. Immunol. 2000;165:4051-4061.
24. Fujioka F, Mukaida N, Harada A et al. Preparation of specific antibodies against murine IL-1ra and the establishment of IL-1ra as an endogenous regulator of bacteria-induced fluminant hepatitis in mice. J. Leukoc. Biol. 1995; 58:90-98.
25. Natsume M, Tsuji H, Harada A et al. Attenuated liver fibrosis and depressed serum albumin levels in carbon tetrachloride-treated IL-6-deficient mice. J. Leukoc. Biol. 1999;66:601-608.
26. Takeda K, Hamelmann E, Joetham A et al. Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell deficient mice. J. Exp. Med. 1997;186:449-454.
27. Konzett H, Rossler R. Versuchanordnung zu Untersuchungen an der Bronchialmusculatur. Arch. Exp. Path. Pharmak. 1940;195:71-74.
28. Jones T, Masson P, Hamel R et al. Biological activity of leukotriene sulfones on respiratory tissues. Prostaglandins 1982;24:279-291.
29. Fujimura M. Inhibitory effect of steroids on slow reacting substance of anaphylaxis (SRS-A) mediated bronchoconstriction in guinea-pigs. Jpn. J. Allergol. 1983;32:365-375.
30. Anguita J, Rincon M, Samanta S, Barthold SW, Flavell RA, Fikrig E. Borrelia burgdorferi-mfected , interleukin-6-deficient mice have decreased Th2 responses and increased Lyme arthritis. J. Infect. Dis. 1998;178:1512-1515.
31. Kovalovich K, DeAngelis RA, Li W, Furth EE, Ciliberto G, Taub R. Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice. Hepatology 2000;31:149-159.
32. Leckie MJ, ten Brinke A, Khan J et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000;356:2114-2116.
33. Crimi E, Spanevello A, Neri M, Ind PW, Rossi GA, Brusasco V. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am. J. Respir. Crit. Care Med. 1998;157:4-9.
34. Takizawa H, Ito K. Interleukin 6 receptors on human bronchial epithelial cells. Jpn. J. Thorac. Dis. 1992;30 (Suppl):77-81.